CompletedEUCTR 2019-003984-24
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In GermanyDepressionHistorical research record
- Countries
- Germany
- Sponsor
- Central Institute of Mental Health
CompletedEUCTR 2010-019369-27
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In HungaryAnxietyHistorical research record
- Countries
- Hungary
- Sponsor
- Anxiofit Ltd.
CompletedNCT06842992
What is this study about?This study evaluated the safety and effectiveness of NH102 for people with depression.
This study has finished and is no longer accepting participants.
Multiple locations, including HefeiDepressionMedication studyAges 18–65
- Countries
- China
- Sponsor
- Jiangsu Nhwa Pharmaceutical Co., Ltd.
CompletedEUCTR 2021-003154-23
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In CroatiaPTSDHistorical research record
- Countries
- Croatia, Finland, Poland, + 1 other
- Sponsor
- Boehringer Ingelheim AB
CompletedNCT01886469
Official study titleA Phase II, Two-Stage, Open-Label, Single-Treatment, Adaptive Trial Design Examining the Pharmacokinetic and Pharmacodynamic Effects of up to Three Separate HLD100 Modified Release Formulations of Dextroamphetamine Sulfate in Adolescent (Stage 1) and Pediatric (Stage 2) Patients With Attention-Deficit Hyperactivity Disorder.
This study has finished and is no longer accepting participants.
In SaskatoonADHDMedication studyAges 6–17
- Countries
- Canada
- Sponsor
- Ironshore Pharmaceuticals and Development, Inc
Active Not RecruitingNCT05733546
About this title
A Phase II, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of COMP360 in Participants With Recurrent Major Depressive Disorder
Read the official source — NCT05733546Official study titleA Phase II, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of COMP360 in Participants With Recurrent Major Depressive Disorder
This study is no longer accepting new participants.
Multiple locations, including La JollaDepressionMedication studyAges 18+
- Countries
- United States
- Sponsor
- COMPASS Pathways
CompletedEUCTR 2015-000222-11
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In United KingdomAddictionHistorical research record
- Countries
- United Kingdom
- Sponsor
- University College London
CompletedEUCTR 2021-002093-34
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In ItalyMental healthHistorical research record
- Countries
- Italy
- Sponsor
- NEWRON PHARMACEUTICALS SPA
CompletedEUCTR 2010-021984-33
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In SlovakiaSchizophreniaHistorical research record
- Countries
- Slovakia
- Sponsor
- F. Hoffmann-La Roche Ltd
CompletedEUCTR 2011-005200-15
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In FinlandDepressionHistorical research record
- Countries
- Finland, Germany, Norway, + 1 other
- Sponsor
- Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.
TerminatedEUCTR 2013-000361-36
This study ended early.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In United KingdomAddictionHistorical research record
- Countries
- United Kingdom
- Sponsor
- Joint Research Office
CompletedEUCTR 2020-003760-11
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In GermanySchizophreniaHistorical research record
- Countries
- Germany, Italy, Norway, + 2 others
- Sponsor
- Boehringer Ingelheim Pharma GmbH & Co. KG